Attention-deficit hyperactivity disorder across the lifespan: authors' reply (letter). . The following interests (declared for the original paper from which this correspondence results) should have been reiterated: A.T.F.B. has received an unrestricted research grant from Eli Lilly and AstraZeneca and has been a speaker for Lundbeck and Eli Lilly. J.J.S.K. is a speaker for Eli Lilly, Janssen and Shire and has received unrestricted research grants for this study from Shire, as well as for another study from Janssen.
No CrossRef data available.
eLetters
No eLetters have been published for this article.